Related Experiment Video
Updated: Jan 21, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Association of Statin Use With Kidney Damage and Function Among HIV-Infected Men
Simon B Ascher1,2, Rebecca Scherzer1, Arvind Nishtala3
1Kidney Health Research Collaborative, Department of Medicine, San Francisco VA Health Care System, University of California, San Francisco, CA.
Insights
Statins did not prevent chronic kidney disease (CKD) in HIV-infected men, though they were linked to higher albumin-to-creatinine ratio (ACR) and a modest slowing of kidney function decline in those with proteinuria.
Area of Science:
- Nephrology
- Infectious Diseases
- Pharmacology
Background:
- Chronic kidney disease (CKD) is prevalent in HIV-infected individuals.
- Statins possess cholesterol-lowering and pleiotropic properties that may mitigate CKD development and progression.
Purpose of the Study:
- To investigate the association between statin use and kidney damage biomarkers in HIV-infected men.
- To evaluate the impact of statins on the progression of kidney function and the incidence of CKD in this population.
Main Methods:
- Cross-sectional and longitudinal analyses were performed on 850 HIV-infected men from the Multicenter AIDS Cohort Study.
- Urine biomarkers of kidney damage and estimated glomerular filtration rate (eGFR) were assessed.
- Inverse probability weighting was used to control for confounding factors related to statin use.
Main Results:
- Statin use was associated with a 4.0% increase in baseline albumin-to-creatinine ratio (ACR) but not other urine biomarkers.
- No overall association was found between statin use and annual eGFR decline.
- Among participants with proteinuria, statin use showed a modest association with slower eGFR decline.
Conclusions:
- Statin use was linked to elevated baseline ACR but not tubulointerstitial injury biomarkers.
- A modest benefit on eGFR decline was observed only in HIV-infected men with pre-existing proteinuria.
- Findings suggest a limited role for statins in reducing CKD risk among HIV-infected men, though confounding by indication is a consideration.
Background:
Chronic kidney disease (CKD) occurs commonly among HIV-infected persons. Statins may delay CKD onset and progression through their cholesterol-lowering and pleiotropic effects.
Methods:
Among 850 HIV-infected men from the Multicenter AIDS Cohort Study with stored urine samples (2009-2011), we evaluated cross-sectional associations of statin use with urine biomarkers of kidney damage [albumin-to-creatinine ratio (ACR), alpha-1-microglobulin, interleukin-18, kidney injury molecule-1, and procollagen type III N-terminal propeptide] using multivariable linear regression. We evaluated the longitudinal associations of statin use with annual change in estimated glomerular filtration rate by creatinine (eGFR) using linear mixed models, and with incident proteinuria and incident CKD (eGFR <60 mL/min/1.73 m) using Cox proportional hazards regression. We used inverse probability weighting to address potential confounding related to statin use.
Results:
Statin users comprised 30% of participants. In adjusted analyses, each year of cumulative statin use was associated with 4.0% higher baseline ACR levels (P = 0.05), but there was no association with baseline levels of other urine biomarkers. Statin use had no overall association with annual eGFR decline. Among participants with baseline proteinuria, statin use was modestly associated with slower annual eGFR decline compared to non-use (adjusted difference: 1.33 mL/min/1.73 m per year; 95% confidence interval: -0.07 to 2.70). Statin use was not associated with risk of incident proteinuria or incident CKD.
Conclusions:
Statin use was associated with higher baseline ACR, but not with biomarkers of tubulointerstitial injury. Statin use was associated with modestly slower eGFR decline only among participants with baseline proteinuria. Although these findings may be susceptible to confounding by indication, they suggest a limited effect of statins on CKD risk among HIV-infected men.
Related Concept Videos
Kidney Structure
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...
Somatosensory, Motor, and Association Cortex
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

